W. E. Aulitzky
- Immunology top 10%
- Immune Response and Inflammation 6
- Immune Cell Function and Interaction 3
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 5
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 5
- Hepatology top 10%
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
-
- Chronic Lymphocytic Leukemia Research 5
-
- Cytomegalovirus and herpesvirus research 4
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Christoph HuberHerbert TilgChristian PeschelChristian G. HuberMJ AmanW. VogelKarin KolbeH. G. Derigs
- Cited by
- ImmunologyOncologyHematology
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
W. E. Aulitzky
29 papers receiving 755 citations
Peers
Comparison fields: 5 of 71
- Immunology 304
- Oncology 284
- Hematology 115
- Hepatology 75
- Transplantation 24
Countries citing papers authored by W. E. Aulitzky
This map shows the geographic impact of W. E. Aulitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. E. Aulitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. E. Aulitzky more than expected).
Fields of papers citing papers by W. E. Aulitzky
This network shows the impact of papers produced by W. E. Aulitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. E. Aulitzky. The network helps show where W. E. Aulitzky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. E. Aulitzky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 5 | |
| 2 | 2011 | 2 | |
| 3 | 2006 | 34 | |
| 4 | 2004 | 8 | |
| 5 | Phase II Study of Rituximab in Combination With Fludarabine in Patients With Chronic Lymphocytic Leukemia | 2002 | 6 |
| 6 | 1997 | 89 | |
| 7 | 1996 | 10 | |
| 8 | Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects. | 1996 | 25 |
| 9 | 1995 | 2 | |
| 10 | 1995 | 42 | |
| 11 | 1995 | 1 | |
| 12 | 1995 | 9 | |
| 13 | 1994 | 16 | |
| 14 | 1993 | 23 | |
| 15 | 1993 | 10 | |
| 16 | 1993 | 77 | |
| 17 | 1992 | 37 | |
| 18 | 1992 | 5 | |
| 19 | 1990 | 65 | |
| 20 | Delayed duct occlusion--a new technique of pancreas transplantation. | 1987 | 2 |
About W. E. Aulitzky
W. E. Aulitzky is a scholar working on Transplantation, Hematology, Genetics, Oncology and Immunology, having authored 30 papers that have together received 781 indexed citations. Recurring topics across this work include Immune Response and Inflammation (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (304 citations), Oncology (284 citations), Hematology (115 citations), Hepatology (75 citations) and Transplantation (24 citations). W. E. Aulitzky has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Christoph Huber, Herbert Tilg, Christian Peschel, Christian G. Huber, MJ Aman, W. Vogel, Karin Kolbe, H. G. Derigs, Charles A. Dinarello and R Margreiter. Their work appears in journals such as Annals of Hematology, Blood, Transplantation, The Journal of Immunology and The Thoracic and Cardiovascular Surgeon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.